Video thumbnail for AstraZeneca shares fall 5% on disappointing lung cancer drug trial results

AstraZeneca shares fall 5% on disappointing lung cancer drug trial results

Sep 10, 2024
techgeeksblogs Logo

techgeeksblogs

AstraZeneca shares fall 5% on disappointing lung cancer drug trial results
#News #Company News #Financial Markets News